Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status ; volume:13 ; number:11 ; day:30 ; month:9 ; year:2023 ; pages:2573-2588 ; date:11.2023
Dermatology and therapy ; 13, Heft 11 (30.9.2023), 2573-2588, 11.2023
- Classification
-
Medizin, Gesundheit
- Creator
-
Casale, Thomas B.
Gimenez-Arnau, Ana Maria
Bernstein, Jonathan A.
Holden, Michael
Zuberbier, Torsten
Maurer, Marcus
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-023-01040-9
- URN
-
urn:nbn:de:101:1-2024011608322154955889
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Casale, Thomas B.
- Gimenez-Arnau, Ana Maria
- Bernstein, Jonathan A.
- Holden, Michael
- Zuberbier, Torsten
- Maurer, Marcus
- SpringerLink (Online service)
Other Objects (12)
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria
Current and Emerging Therapies for Chronic Spontaneous Urticaria: A Narrative Review
Erfolgreiche Behandlung der Urticaria solaris mit Omalizumab
Omalizumab for chronic urticaria in Latin America
Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
Omalizumab Use in Chronic Spontaneous Urticaria during Pregnancy and a Four Years’ Follow-Up: A Case Report
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
T cell activity in successful treatment of chronic urticaria with omalizumab
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
Long term treatment with omalizumab in adolescent with refractory solar urticaria
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria
Current and Emerging Therapies for Chronic Spontaneous Urticaria: A Narrative Review
Erfolgreiche Behandlung der Urticaria solaris mit Omalizumab
Omalizumab for chronic urticaria in Latin America
Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
Omalizumab Use in Chronic Spontaneous Urticaria during Pregnancy and a Four Years’ Follow-Up: A Case Report
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
T cell activity in successful treatment of chronic urticaria with omalizumab
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
Long term treatment with omalizumab in adolescent with refractory solar urticaria
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria
Current and Emerging Therapies for Chronic Spontaneous Urticaria: A Narrative Review
Erfolgreiche Behandlung der Urticaria solaris mit Omalizumab
Omalizumab for chronic urticaria in Latin America
Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
Omalizumab Use in Chronic Spontaneous Urticaria during Pregnancy and a Four Years’ Follow-Up: A Case Report
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
T cell activity in successful treatment of chronic urticaria with omalizumab
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria